Tirzepatide, a groundbreaking drug, represents a significant innovation in the treatment of type 2 diabetes and, more recently, obesity. This dual agonist acts upon two crucial hormones: incretin hormone and gastric inhibitory polypeptide. Unlike traditional diabetes drugs, Tirzepatide encourages not only insulin release when blood sugar concentrat